Tivic Health Systems, Inc. (TIVC): שווי פעילות לרווח לפני ריבית, מסים ופחת

The quotes provided below demonstrate the EV/EBITDA of Tivic Health Systems (TIVC), which stands at 0.00. The business generates revenue through the sale of portable gadgets for rhinitis treatment, where the regular replacement of consumables ensures a steady cash flow. The brand is valued for its clinically validated, safe bioelectronic innovations. The company is currently scaling its e-commerce operations, promoting ClearUP as an effective alternative to medication.

Shifting the production of bioelectronic devices to US outsourcing while maintaining control over IP requires precise monitoring of the debt load. Analyzing the EV/EBITDA ratio of this capital-intensive business, the investor sees a current value of 0.00. This metric correlates the total enterprise value with operating profit before taxes and depreciation, determining the asset payback period and confirming the financial stability of Tivic Health Systems (TIVC).